

Catalog illustration. Actual packaging and lot details are confirmed on inquiry.
BPC-157 10 mg + TB-500 10 mg Blend 20 mg
- Per vial
- 20 mg
- Per box
- 10 vials
- Product code
- BB20
BPC-157 10 mg + TB-500 10 mg Blend 20 mg is listed at 20 mg per vial, 10 vials per box, under product code BB20. It is the largest of 2 BPC-157 + TB-500 Blend presentations in the catalog, which range from 10 mg to 20 mg per vial. BPC-157 + TB-500 blends combine the two peptides in equal amounts per vial, listed as 5 mg + 5 mg and 10 mg + 10 mg presentations for tissue-repair research.
Let’s put your request together.
Ask for this material’s price, or use + to include it in a combined inquiry.
Presentation: 20 mg per vial, 10 vials/box
Minimum quantity: 1 · Availability confirmed on inquiry
No payment is taken here. Confirm specifications, quantities and shipping with our team on WhatsApp.
| Product code | BB20 |
|---|---|
| Supplier presentation | 20 mg per vial, 10 vials/box |
| Intended use | Laboratory research only |
Catalog fields are general product information. Confirm the actual label, current lot specification and available documents before relying on a value for procurement or research planning.
Research Use Only. This product is intended strictly for laboratory research. It is not a drug, supplement or medical product and is not for human or veterinary consumption.
About BPC-157 + TB-500 Blend
These listings combine BPC-157, the 15-amino-acid gastric-protein-derived peptide, with TB-500 in a single vial at a 1:1 ratio by mass. Two fills are listed: 5 mg of each peptide (10 mg total) and 10 mg of each (20 mg total).
What to confirm for BPC-157 + TB-500 Blend
Check these points with our team before you order:
- The component amounts per vial and that the lot documents identify both peptides.
- Which form of TB-500 the blend contains: full-length thymosin β4 or a fragment.
- The number of boxes you need and the US delivery destination.
- Which lot documents you require before ordering, such as an identity or purity report.


